Correlation Between Stoke Therapeutics and Talaris Therapeutics
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Talaris Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Talaris Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Talaris Therapeutics, you can compare the effects of market volatilities on Stoke Therapeutics and Talaris Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Talaris Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Talaris Therapeutics.
Diversification Opportunities for Stoke Therapeutics and Talaris Therapeutics
-0.48 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Stoke and Talaris is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Talaris Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Talaris Therapeutics and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Talaris Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Talaris Therapeutics has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Talaris Therapeutics go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Talaris Therapeutics
If you would invest 1,127 in Stoke Therapeutics on November 2, 2024 and sell it today you would lose (28.00) from holding Stoke Therapeutics or give up 2.48% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 5.26% |
| Values | Daily Returns |
Stoke Therapeutics vs. Talaris Therapeutics
Performance |
| Timeline |
| Stoke Therapeutics |
| Talaris Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Stoke Therapeutics and Talaris Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Talaris Therapeutics
The main advantage of trading using opposite Stoke Therapeutics and Talaris Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Talaris Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Talaris Therapeutics will offset losses from the drop in Talaris Therapeutics' long position.| Stoke Therapeutics vs. Surrozen | Stoke Therapeutics vs. Armata Pharmaceuticals | Stoke Therapeutics vs. Pasithea Therapeutics Corp | Stoke Therapeutics vs. Aditxt Inc |
| Talaris Therapeutics vs. Edgewise Therapeutics | Talaris Therapeutics vs. Adicet Bio | Talaris Therapeutics vs. Cullinan Oncology LLC | Talaris Therapeutics vs. Vor Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |